Main news


Good Performance for Universal CVD Risk Prediction Model A universal cardiovascular disease (CVD) prediction tool performs well in patients with and without atherosclerotic CVD (ASCVD), a new study showed, suggesting this model could facilitate transition from primary to secondary prevention by streamlining risk classification.



Long-term cardiac follow-up of athletes infected with SARS-CoV-2 after resumption of elite-level sports Longitudinal consequences and potential interactions of COVID-19 and elite-level sports and exercise are unclear. Therefore, scientists determined the long-term detrimental cardiac effects of the interaction between SARS-CoV-2 infection and the highest level of sports and exercise.



Deaths Linked to Substance Use, CVD on the Rise Deaths caused by both substance use (SU) and cardiovascular disease (CVD) increased substantially in the United States between 1999 and 2019, with the most pronounced rise among women, American Indians, younger people, rural residents, and users of cannabis and psychostimulants, results of new research suggest.



Colchicine May Benefit Patients With Diabetes and Recent MI A daily low dose of colchicine significantly reduces ischemic cardiovascular events in patients with type 2 diabetes (T2D) and a recent myocardial infarction (MI).



New Insights Into Mortality in Takotsubo Syndrome Mortality in patients with takotsubo syndrome (TTS), sometimes called broken heart syndrome or stress-induced cardiomyopathy is substantially higher than that in the general population and comparable with that in patients having myocardial infarction (MI), results of a new case-control study showed. The rates of medication use are similar for TTS and MI, despite no current clinical trials or recommendations to guide such therapies, the authors noted.



Association between catheter ablation of atrial fibrillation and mortality or stroke Catheter ablation of atrial fibrillation was associated with a reduction in the primary endpoint of all-cause mortality or stroke. This result was driven by a marked reduction in all-cause mortality.



Death of a Sibling Linked to an Increased Risk for Early-Onset Heart Disease People who experience the death of a sibling as children or in adulthood may be at an increased risk of developing cardiovascular illnesses.



Short-Stay Units May Be a Safe Alternative for Patients With HF Quality of life for patients with acute heart failure (AHF) managed in a short-term unit (SSU) is no worse than that for those who are hospitalized, a new randomized trial showed. They also had an increased chance of being alive and out of hospital at 30 days and did not experience more adverse events, results suggested.



New Insights Into Mortality in Takotsubo Syndrome Quality of life for patients with acute heart failure (AHF) managed in a short-term unit (SSU) is no worse than that for those who are hospitalized, a new randomized trial showed. They also had an increased chance of being alive and out of hospital at 30 days and did not experience more adverse events, results suggested.



Study Identifies Cardiovascular Comorbidities Associated With Dermatomyositis Dermatomyositis (DM) is associated with an increased risk for cardiovascular comorbidities, including chronic kidney disease, a new study found.


Lower CVD Risk With Stable DMARD Therapy in Seropositive Rheumatoid Arthritis
Lower CVD Risk With Stable DMARD Therapy in Seropositive Rheumatoid Arthritis The risk for cardiovascular diseases (CVDs) is lower in patients with seropositive rheumatoid arthritis (RA) who remain on stable disease-modifying antirheumatic drug (DMARD) therapy than in those whose treatment regimen is not stable.


Novel PCSK9 Inhibitor Reduced LDL by 50%
Novel PCSK9 Inhibitor Reduced LDL by 50% Lerodalcibep, a novel, third-generation proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, reduced low-density lipoprotein cholesterol (LDL-C) by more than 50% after 1 year in patients with or at a high risk for cardiovascular disease (CVD), new phase 3 results showed.


Editorial Activity

cardiology book

Recommendations for magnetic resonance imaging in patients with cardiac implantable electronic devices
Recommendations for magnetic resonance imaging in patients with cardiac implantable electronic devices Over the last several decades, magnetic resonance (MR) imaging has become the diagnostic modality of choice for several conditions, cardiac and non-cardiac. However, MR uses a static magnetic field, gradient magnetic fields and pulsed radiofrequency energy, all of which may interact with metallic and electronic components within the field. As such, patients with cardiac implantable electronic devices (CIEDs) have traditionally been precluded from MR imaging given the potential harm from mechanical force and torque, heating and tissue damage, unwanted myocardial stimulation or electrical reset.


Cancer Identified as a New Cardiovascular Risk Factor
Cancer Identified as a New Cardiovascular Risk Factor A history of cancer is an independent predictor of major cardiovascular events in patients undergoing coronary angioplasty. Cancer should be considered a new cardiovascular risk factor in primary and secondary prevention.


Management of arrhythmogenic right ventricular cardiomyopathy
Management of arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a disease characterised by fibrofatty replacement of the ventricular myocardium due to specific mutations, leading to ventricular arrhythmias and sudden cardiac death. Treating this condition can be challenging due to progressive fibrosis, phenotypic variations and small patient cohorts limiting the feasibility of conducting meaningful clinical trials.


Mortality Still Significant in High-Risk PE Despite Advances
Mortality Still Significant in High-Risk PE Despite Advances 1 in 5 patients with high-risk pulmonary embolism (PE) and more than 2 in 5 with catastrophic PE with hemodynamic collapse die in the hospital, a large contemporary analysis showed.


ECG Deep-Learning Algorithm Predicts Mortality Post Surgery
ECG Deep-Learning Algorithm Predicts Mortality Post Surgery Algorithm interpreting preoperative ECGs can identify risk for postoperative death in those undergoing cardiac surgery, noncardiac surgery, and interventional procedures, a large new study showed. The algorithm was more effective in identifying high-risk patients who went on to experience postoperative mortality than a widely used risk tool.


FDA Approves First Pulsed Field Ablation System for AF
FDA Approves First Pulsed Field Ablation System for AF The US Food and Drug Administration (FDA) has approved the PulseSelect Pulsed Field Ablation (PFA) System (Medtronic) for the treatment of both paroxysmal and persistent atrial fibrillation (AF), the manufacturer has announced.


A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic Syndrome
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic Syndrome A growing appreciation of the pathophysiological interrelatedness of metabolic risk factors such as obesity and diabetes, chronic kidney disease, and cardiovascular disease has led to the conceptualization of cardiovascular-kidney-metabolic syndrome. The confluence of metabolic risk factors and chronic kidney disease within cardiovascular-kidney-metabolic syndrome is strongly linked to risk for adverse cardiovascular and kidney outcomes.


In memory of Umida Kabirovna Kamilova
In memory of Umida Kabirovna Kamilova November 21, 2023. Passed away at the age of 61. Professor Umida Kabirovna Kamilova, Doctor of Medical Sciences. She devoted her life and work to medicine.